TRDA
Entrada Therapeutics, Inc. · Healthcare
Director Kush Parmar sold $807K of Entrada Therapeutics, Inc.
Sold$807,027
$6.93Price
116,474Shares
−4%Stake
What TRDA did after the filing
- The stock from Tue, Aug 4 open, $6.95
- −0.6%
- S&P 500, same days
- +0.3%
Measured over 30 trading days, to the Sep 17 close.
Traded Thu, Jul 30. Filed Mon, Aug 3, 5:26 PM ET, after the close. Returns use the Aug 4 open and the Sep 17 close. Not investment advice.